Adzenys XR-ODT is a prescription stimulant medication used to treat attention deficit hyperactivity disorder (ADHD). It contains amphetamine, the same active ingredient found in Adderall XR, but comes as an extended-release tablet that dissolves on the tongue instead of being swallowed whole. This makes it particularly useful for children or adults who have difficulty swallowing pills.
How Adzenys Works
Like other amphetamine-based ADHD medications, Adzenys increases the levels of two key brain chemicals: dopamine and norepinephrine. It does this in two ways. First, it blocks nerve cells from reabsorbing these chemicals after they’ve been released. Second, it triggers nerve cells to push more of these chemicals out into the surrounding space. The combined effect improves focus, impulse control, and the ability to stay on task. The exact reason this helps with ADHD symptoms isn’t fully understood, but the increase in dopamine and norepinephrine activity in the brain is the leading explanation.
What Makes It Different From Adderall XR
Adzenys XR-ODT is bioequivalent to Adderall XR, meaning your body absorbs the same amount of medication at the same rate. FDA bridging studies confirmed that blood levels of both forms of amphetamine in Adzenys matched those of Adderall XR within the standard 80% to 125% range. In practical terms, the two medications are expected to have the same effectiveness and safety profile.
The key difference is the delivery format. Adzenys is an orally disintegrating tablet (ODT) that dissolves in saliva on your tongue, so you don’t need water and you don’t need to swallow a capsule. This can be a real advantage for younger children, people with swallowing difficulties, or anyone who simply prefers not to take traditional pills. The medication is manufactured by Aytu BioPharma, based in Denver, Colorado.
Available Strengths and How to Take It
Adzenys XR-ODT comes in six strengths: 3.1 mg, 6.3 mg, 9.4 mg, 12.5 mg, 15.7 mg, and 18.8 mg. These unusual-looking numbers correspond to specific Adderall XR dose equivalents, adjusted for the different formulation.
You take it once daily in the morning, with or without food. The tablet comes in individual blister packs, and proper handling matters. Keep each tablet sealed until you’re ready to take it. Open the blister with dry hands by tearing along the perforation and peeling back the labeled foil backing. Don’t push the tablet through the foil, as that can damage it. Place it directly on your tongue, let it dissolve in your saliva, and swallow. Don’t crush or chew it.
Common Side Effects
Because Adzenys contains the same active ingredient as other amphetamine medications, its side effect profile is similar. In clinical studies, the most frequently reported side effects in adults were decreased appetite (2% to 5%), dry mouth (1% to 2%), and insomnia (1%). Appetite suppression tends to be the most noticeable effect for many people, particularly in children. Taking the medication in the morning helps reduce sleep problems, since the extended-release formula is designed to wear off by evening.
Who Should Not Take It
Adzenys is not safe for everyone. You should not take it if you have a known allergy to amphetamine or any of the tablet’s inactive ingredients. Allergic reactions including severe swelling and anaphylaxis have been reported with amphetamine products, though these are rare.
The other major restriction involves a class of medications called MAO inhibitors, sometimes prescribed for depression or Parkinson’s disease. Taking Adzenys while on an MAO inhibitor, or within 14 days of stopping one, creates a risk of a dangerous spike in blood pressure. The antibiotic linezolid also falls into this category because it has MAO-inhibiting properties.
As a Schedule II controlled substance, Adzenys carries a risk of misuse and dependence, the same classification given to all amphetamine-based medications. This is a standard regulatory designation for stimulants rather than something unique to this particular product.
How Adzenys Compares to Other ADHD Options
The ADHD medication landscape includes dozens of options, and Adzenys fills a specific niche. For someone who responds well to mixed amphetamine salts (the type of amphetamine in Adderall) but struggles with swallowing capsules, it offers the same drug in a more convenient form. It provides extended-release coverage throughout the day from a single morning dose, similar to Adderall XR, Vyvanse, and other long-acting stimulants.
If you’re already stable on Adderall XR and considering a switch, the bioequivalence data means the transition is relatively straightforward, though your prescriber will still want to confirm the right dose. The unusual tablet strengths can make it slightly less intuitive to compare doses, so it helps to discuss the equivalent milligram conversion directly.